“Recombinant Human Erythropoietin (rHuEPO) Reduces Transfusion Requirements in Anaemia of Prematurity”. Northern International Medical College Journal, vol. 6, no. 2, May 2015, pp. 53-56, https://doi.org/10.3329/nimcj.v6i2.23171.